Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean basin

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Zehender, Gianguglielmo ^a   Ebranati, Erika ^a   Gabanelli, Elena ^a   Shkjezi, Renata ^a   Lai, Alessia ^a   Sorrentino, Chiara ^a   Presti, Alessandra Lo ^b   Basho, Mimoza ^c   Bruno, Raffaele ^d   Tanzi, Elisabetta ^e   Bino, Silvia ^f   Ciccozzi, Massimo ^b   Galli, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Public Health Institute   (Albania)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBANIA; ARTICLE; ASIA; BAYES THEOREM; CONTROLLED STUDY; EASTERN EUROPE; EPIDEMIC; EUROPE; EVOLUTIONARY RATE; GENE CONSTRUCT; GENE SEQUENCE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B VIRUS D; INDIA; INDIAN; MICROBIAL POPULATION DYNAMICS; MIDDLE EAST; NONHUMAN; NORTH AFRICA; P GENE; PHYLOGENETIC TREE ROOT; PHYLOGEOGRAPHY; POPULATION DISPERSION; PROBABILITY; SOUTHERN EUROPE; USSR; VIRUS GENE; VIRUS ISOLATION;

BAYES THEOREM; DATABASES, NUCLEIC ACID; EUROPE; EVOLUTION, MOLECULAR; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; PHYLOGENY; PHYLOGEOGRAPHY;

HEPATITIS B VIRUS;

EID: 84861467079     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037198     Document Type: Article

References (72)

1. Ott JJ, Stevens GA, Groeger J, Wiersma ST, (2012) Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 30 (12): 2212-9.
2. European Centre for Disease prevention and Control (2010) Hepatitis B and C in the EU neighbourhood: prevalence, burden of disese and screening policies. Stockholm. ECDC.
3. Da Villa G, Romano L, Sepe A, Iorio R, Paribello N, et al. (2007) Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 25: 3133-3136.
4. Rantala M, van de Laar MJ, (2008) Surveillance and epidemiology of hepatitis B and C in Europe-a review. 21 Euro Surveill 13.
5. Schaefer S, (2007) Hepatitis B virus genotypes in Europe. Hepatol Res 37: S20-26.
6. Schaefer S, (2007) Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13: 14-21.
7. Bozdayi G, Turkyilmaz AR, Idilman R, Karatayli E, Rota S, et al. (2005) Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol 76: 476-481.
8. Cox LE, Arslan O, Allain JP, (2011) Characterization of hepatitis B virus in Turkish blood donors, and the prevalence of the SP1 splice variant. J Med Virol 83: 1321-1325.
9. Fylaktou A, Papaventsis D, Daoudaki M, Moskophidis M, Reiberger T, et al. (2011) Molecular epidemiology of chronic hepatitis B virus infection in Greece. J Med Virol 83: 245-252.
10. Garmiri P, Rezvan H, Abolghasemi H, Allain JP, (2011) Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol 83: 948-952.
11. Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, et al. (2008) D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 89: 1829-1839.
12. Zehender G, Shkjezi R, Ebranati E, Gabanelli E, Abazaj Z, et al. (2011) Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infect Genet Evol 12 (2): 291-8.
13. De Maddalena C, Giambelli C, Tanzi E, Colzani D, Schiavini M, et al. (2007) High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus. Virology 365: 113-124.
14. Kimbi GC, Kramvis A, Kew MC, (2004) Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol 85: 1211-1220.
15. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, et al. (2007) Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol 152: 2017-2025.
16. Kitab B, El Feydi AE, Afifi R, Derdabi O, Cherradi Y, et al. (2011) Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 63: 66-75.
17. Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP, (2009) A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90: 1622-1628.
18. Lusida MI, Nugrahaputra VE, Soetjipto, Handajani R, Nagano-Fujii M, et al. (2008) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46: 2160-2166.
19. Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, et al. (2006) Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol 78: 1164-1174.
20. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, et al. (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
21. Lemey P, Rambaut A, Drummond AJ, Suchard MA, (2009) Bayesian phylogeography finds its roots. PLoS Comput Biol 5: e1000520.
22. Zehender G, Maddalena CD, Giambelli C, Milazzo L, Schiavini M, et al. (2008) Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. Virology 380: 84-90.
23. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
24. Schmidt HA, Strimmer K, Vingron M, von Haeseler A, (2002) TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18: 502-504.
25. Strimmer K, von Haeseler A, (1997) Likelihood-mapping: a simple method to visualize phylogenetic content of a sequence alignment. Proc Natl Acad Sci U S A 94: 6815-6819.
26. Hue S, Pillay D, Clewley JP, Pybus OG, (2005) Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci U S A 102: 4425-4429.
27. Ciccozzi M, Ciccaglione A, Presti AL, Yalcinkaya T, Taskan ZP, et al. (2011) Reconstruction of the evolutionary dynamics of the hepatitis C virus 1b epidemic in Turkey. Infect Genet Evol 11 (5): 863-8.
28. Posada D, (2008) jModelTest: phylogenetic model averaging. Mol Biol Evol 25: 1253-1256.
29. Drummond AJ, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
30. Suchard MA, Weiss RE, Sinsheimer JS, (2001) Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol 18: 1001-1013.
31. Kass RE, Raftery AE, (1995) Bayes factors. Journal of American Statistical Association 90: 773-795.
32. Bielejec F, Rambaut A, Suchard MA, Lemey P, (2011) SPREAD: spatial phylogenetic reconstruction of evolutionary dynamics. Bioinformatics 27: 2910-2912.
33. Murhekar MV, Murhekar KM, Sehgal SC, (2008) Epidemiology of hepatitis B virus infection among the tribes of Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg 102: 729-734.
34. Fares MA, Holmes EC, (2002) A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54: 807-814.
35. Hannoun C, Horal P, Lindh M, (2000) Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 81: 75-83.
36. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, et al. (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69: 2575-2583.
37. Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, et al. (1989) Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci U S A 86: 7059-7062.
38. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY, (2006) Molecular evolution of hepatitis B virus over 25 years. J Virol 80: 10307-10314.
39. Zhou Y, Holmes EC, (2007) Bayesian estimates of the evolutionary rate and age of hepatitis B virus. J Mol Evol 65: 197-205.
40. Harrison A, Lemey P, Hurles M, Moyes C, Horn S, et al. (2011) Genomic analysis of hepatitis B virus reveals antigen state and genotype as sources of evolutionary rate variation. Viruses 3: 83-101.
41. Lindh M, Andersson AS, Gusdal A, (1997) Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 175: 1285-1293.
42. Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, et al. (2009) Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 16: 749-756.
43. Ghosh S, Banerjee P, RoyChoudhury A, Sarkar S, Ghosh A, et al. (2011) Unique hepatitis B virus subgenotype in a primitive tribal community in eastern India. J Clin Microbiol 48: 4063-4071.
44. Kato H, Ruzibakiev R, Yuldasheva N, Hegay T, Kurbanov F, et al. (2002) Hepatitis B virus genotypes in Uzbekistan and validity of two different systems for genotyping. J Med Virol 67: 477-483.
45. Khan A, Kurbanov F, Tanaka Y, Elkady A, Sugiyama M, et al. (2008) Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J Med Virol 80: 268-276.
46. Tallo T, Norder H, Tefanova V, Krispin T, Priimagi L, et al. (2004) Hepatitis B virus genotype D strains from Estonia share sequence similarity with strains from Siberia and may specify ayw4. J Med Virol 74: 221-227.
47. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P, et al. (2012) Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study. J Med Virol 84: 414-423.
48. Ahmed CS, Wang ZH, Bin Z, Chen JJ, Kamal M, et al. (2009) Hepatitis B virus genotypes, subgenotypes, precore, and basal core promoter mutations in the two largest provinces of Pakistan. J Gastroenterol Hepatol 24: 569-573.
49. Baig S, Siddiqui A, Chakravarty R, Moatter T, (2009) Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes 2: 1.
50. Amini-Bavil-Olyaee S, Alavian SM, Adeli A, Sarrami-Forooshani R, Sabahi F, et al. (2006) Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J Med Virol 78: 358-364.
51. Deterding K, Constantinescu I, Nedelcu FD, Gervain J, Nemecek V, et al. (2008) Prevalence of HBV genotypes in Central and Eastern Europe. J Med Virol 80: 1707-1711.
52. Olinger CM, Lazouskaya NV, Eremin VF, Muller CP, (2008) Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences. Clin Microbiol Infect 14: 575-581.
53. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, et al. (2010) Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia. J Med Virol 82: 1160-1167.
54. Panessa C, Hill WD, Giles E, Yu A, Harvard S, et al. (2009) Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J Viral Hepat 16: 64-73.
55. Pourkarim MR, Amini-Bavil-Olyaee S, Verbeeck J, Lemey P, Zeller M, et al. (2009) Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations. J Med Virol 82: 379-389.
56. Swenson PD, Van Geyt C, Alexander ER, Hagan H, Freitag-Koontz JM, et al. (2001) Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA. J Med Virol 64: 305-311.
57. Reuben A, (2002) The thin red line. Hepatology 36: 770-773.
58. Frierson JG, (2010) The yellow fever vaccine: a history. Yale J Biol Med 83: 77-85.
59. Oliphant JW, (1944) Jaundice Following Administration of Human Serum. Bull N Y Acad Med 20: 429-445.
60. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, et al. (1987) A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 316: 965-970.
61. Mortimer, (1995) Arsphenamine jaundice and the recognition of instrument-borne virus infection. Genitourin Med 71 (2): 109-19.
62. Zuckerman JN, Zuckerman AJ, (1999) THE EPIDEMIOLOGY OF HEPATITIS B. Clinics in Liver Disease 3: 179-187.
63. Hadziyannis SJ, (2011) Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol 55 (1): 183-91.
64. Alavian SM, Fallahian F, Lankarani KB, (2007) The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 16: 403-406.
65. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, et al. (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38: S158-168.
66. Hutin YJ, Hauri AM, Armstrong GL, (2003) Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ 327: 1075.
67. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M, (1999) Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ 77: 801-807.
68. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M, (1999) Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 77: 789-800.
69. Hutin YJ, Harpaz R, Drobeniuc J, Melnic A, Ray C, et al. (1999) Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 28: 782-786.
70. Dentinger C, Pasat L, Popa M, Hutin YJ, Mast EE, (2004) Injection practices in Romania: progress and challenges. Infect Control Hosp Epidemiol 25: 30-35.
71. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, et al. (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378: 571-583.
72. van Houdt R, Bruisten SM, Geskus RB, Bakker M, Wolthers KC, et al. (2010) Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. J Viral Hepat 17: 108-114.